Walgreens Boots Alliance (Nasdaq:WBA) - Prezzo delle azioni, notizie e analisi

WBA Panoramica delle azioni

Walgreens Boots Alliance, Inc. opera come azienda sanitaria, farmaceutica e di vendita al dettaglio negli Stati Uniti, in Germania, nel Regno Unito e a livello internazionale. Maggiori dettagli

WBA analisi fondamentale
Punteggio fiocco di neve
Valutazione	5/6
Crescita futura	3/6
Prestazioni passate	0/6
Salute finanziaria	0/6
Dividendi	2/6

Premi

Negoziato a 48.3% al di sotto della nostra stima del suo valore equo

Si prevede che gli utili cresceranno del 106.56% all'anno

Negoziato a un buon valore rispetto ai pari e al settore

Analisi del rischio

I pagamenti degli interessi non sono ben coperti dagli utili

Il dividendo di 12.14% non è ben coperto dagli utili o dai flussi di cassa liberi

Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

WarrenAI

Based on Analyst Price Targets

Strategic Store Footprint And Brand Focus To Enhance Margins And Cash Flow

Key Takeaways Strategic focus on retail pharmacy strengths and store optimization is aimed at stabilizing core economics and enhancing revenue growth. Initiatives on owned brand expansion and cost discipline target improved margins and operating income stability.

View narrative

US$10.81

23.8% undervalued

1.38%

Revenue growth p.a.

Updated

Walgreens Boots Alliance, Inc. Concorrenti

Guardian Pharmacy Services

NYSE:GRDN

US$1.4b

Albertsons Companies

NYSE:ACI

US$11.2b

BJ's Wholesale Club Holdings

NYSE:BJ

US$11.4b

Sprouts Farmers Market

NasdaqGS:SFM

US$14.3b

Storia dei prezzi e prestazioni

Riepilogo dei massimi storici, delle variazioni e dei cali di prezzo di tutti i tempi per Walgreens Boots Alliance
Prezzi storici delle azioni
Prezzo attuale dell'azione	US$8.24
Massimo di 52 settimane	US$27.05
Minimo di 52 settimane	US$8.11
Beta	0.67
1Variazione di 1 mese	-21.15%
Variazione a 3 mesi	-17.85%
Variazione di 1 anno	-60.17%
3Variazione a 3 anni	-82.33%
Variazione a 5 anni	-86.29%
Variazione dall'IPO	2,472.48%

Notizie e aggiornamenti recenti

Walgreens: 11.9% Dividend Yield Still On Unsteady Legs

Nov 18

Walgreens Q4: 2 Signs Of A Dividend Trap

Oct 29

Walgreens: Undervalued Pharma Giant Poised For A Turnaround Amid Cost-Cutting And Activist Investor Potential

Oct 23

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?

Oct 17

Recent updates

Walgreens: 11.9% Dividend Yield Still On Unsteady Legs

Nov 18

Walgreens Q4: 2 Signs Of A Dividend Trap

Oct 29

Walgreens: Undervalued Pharma Giant Poised For A Turnaround Amid Cost-Cutting And Activist Investor Potential

Oct 23

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?

Oct 17

Walgreens Boots Alliance: Likely A Value Trap, But Could Be A Speculative Long-Term Play

Aug 13

Walgreens: A Painful Turnaround Lesson

Aug 02

Walgreens: Here's What Comes Next

Jul 09

Walgreens: Yielding Over 8% Following The Earnings Drop

Jul 02

Walgreens: Beware The Value Trap Ahead Of Earnings

Jun 24

Walgreens: Another Dividend Cut Could Be Coming Soon (Rating Downgrade)

May 30

5 Reasons Walgreens Fell By 6.4% To Nearly 25-Year Lows

May 22

Walgreens: Hold Tight, Let It Turn Around First

May 06

Walgreens Boots Alliance (NASDAQ:WBA) Use Of Debt Could Be Considered Risky

May 05

3 Reasons Walgreens Can See Upside (Rating Upgrade)

Apr 10

Investors Still Waiting For A Pull Back In Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Apr 08

Walgreens: New Management Team And Cost-Plus Model Are Exactly What The Doctor Prescribed

Apr 04

Walgreens Earnings Preview: Revenue Estimates Holding Up; It's A Cost Structure Problem

Mar 27

Walgreens' Strategic Pivot

Mar 21

Walgreens Q2, Dow Exit, And Bet Against Wall Street

Mar 15

Walgreens: New CEO Looking To Right The Ship

Feb 13

Walgreens Boots Alliance (NASDAQ:WBA) Use Of Debt Could Be Considered Risky

Jan 19

Walgreens Boots Alliance: Income Opportunity After Dividend Cut

Jan 17

Walgreens Q1: Dividend Cut Now What? (Rating Upgrade)

Jan 10

After Leaping 26% Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Are Not Flying Under The Radar

Dec 24

Walgreens Boots Alliance's (NASDAQ:WBA) Dividend Will Be $0.48

Oct 31

Walgreens Boots Alliance (NASDAQ:WBA) Has A Somewhat Strained Balance Sheet

Oct 02

Rendimenti per gli azionisti

	WBA	US Consumer Retailing	US Mercato
7D	-8.7%	-1.0%	-1.0%
1Y	-60.2%	45.0%	30.3%

Ritorno vs Industria: WBA ha avuto una performance inferiore rispetto al US Consumer Retailing che ha registrato un rendimento 45 % nell'ultimo anno.

Rendimento vs Mercato: WBA ha avuto una performance inferiore al mercato US che ha registrato un rendimento 30.3 % nell'ultimo anno.

Volatilità dei prezzi

Is WBA's price volatile compared to industry and market?
WBA volatility
WBA Average Weekly Movement	7.7%
Consumer Retailing Industry Average Movement	6.7%
Market Average Movement	6.2%
10% most volatile stocks in US Market	15.7%
10% least volatile stocks in US Market	3.1%

Prezzo delle azioni stabile: WBA non ha avuto una volatilità dei prezzi significativa negli ultimi 3 mesi.

Volatilità nel tempo: La volatilità settimanale ( 8% ) di WBA è rimasta stabile nell'ultimo anno.

Informazioni sull'azienda

Fondato	I dipendenti	AMMINISTRATORE DELEGATO	Sito web
1909	252,500	Tim Wentworth	www.walgreensbootsalliance.com

Walgreens Boots Alliance, Inc. opera nel settore sanitario, farmaceutico e della vendita al dettaglio negli Stati Uniti, in Germania, nel Regno Unito e a livello internazionale. Opera attraverso tre segmenti: U.S. Retail Pharmacy, International e U.S.

Walgreens Boots Alliance, Inc. Riepilogo dei fondamenti

Come si confrontano gli utili e i ricavi di Walgreens Boots Alliance con la sua capitalizzazione di mercato?
WBA statistiche fondamentali
Capitalizzazione di mercato	US$7.17b
Guadagni(TTM)	-US$8.64b
Ricavi(TTM)	US$147.66b

0.0x

Rapporto P/S

-0.8x

Rapporto P/E

WBA è sopravvalutato?

Vedi Fair Value e analisi di valutazione

Guadagni e ricavi

Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM)
WBA Conto economico (TTM)
Ricavi	US$147.66b
Costo del fatturato	US$121.13b
Profitto lordo	US$26.52b
Altre spese	US$35.16b
Guadagni	-US$8.64b

Ultimi guadagni dichiarati

Aug 31, 2024

Prossima data di guadagno

n/a

Utile per azione (EPS)	-9.99
Margine lordo	17.96%
Margine di profitto netto	-5.85%
Rapporto debito/patrimonio netto	78.4%

Come si è comportato WBA nel lungo periodo?

Vedi performance storica e confronto

Dividendi

12.1%

Rendimento attuale del dividendo

-12%

Rapporto di remunerazione

WBA paga dividendi affidabili?

Vedere la storia dei dividendi e i benchmark di WBA

Quando è necessario acquistare WBA per ricevere un dividendo imminente?
Walgreens Boots Alliance date dei dividendi
Data di stacco del dividendo	Nov 18 2024
Data di pagamento dei dividendi	Dec 12 2024
Giorni fino al dividendo Ex	3 days
Giorni prima della data di pagamento dei dividendi	21 days

WBA paga dividendi affidabili?

Vedere la storia dei dividendi e i benchmark di WBA

WBA Panoramica delle azioni

Premi

Analisi del rischio

Strategic Store Footprint And Brand Focus To Enhance Margins And Cash Flow

Walgreens Boots Alliance, Inc. Concorrenti

NYSE:GRDN

US$1.4b

NYSE:ACI

US$11.2b

NYSE:BJ

US$11.4b

NasdaqGS:SFM

US$14.3b

Storia dei prezzi e prestazioni

Notizie e aggiornamenti recenti

Walgreens: 11.9% Dividend Yield Still On Unsteady Legs

Walgreens Q4: 2 Signs Of A Dividend Trap

Walgreens Boots Alliance Declares Quarterly Dividend, Payable on December 12, 2024

Walgreens: Undervalued Pharma Giant Poised For A Turnaround Amid Cost-Cutting And Activist Investor Potential

Walgreens Boots Alliance, Inc. Expects to Close Approximately 1,200 Stores over the Next 3 Years with About 500 Targeted to Close in Fiscal 2025

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?

Recent updates

Walgreens: 11.9% Dividend Yield Still On Unsteady Legs

Walgreens Q4: 2 Signs Of A Dividend Trap

Walgreens Boots Alliance Declares Quarterly Dividend, Payable on December 12, 2024

Walgreens: Undervalued Pharma Giant Poised For A Turnaround Amid Cost-Cutting And Activist Investor Potential

Walgreens Boots Alliance, Inc. Expects to Close Approximately 1,200 Stores over the Next 3 Years with About 500 Targeted to Close in Fiscal 2025

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?

Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Walgreens: A Turnaround Stock To Avoid

Walgreens Boots Alliance, Inc. Provides Earnings Guidance for the Fiscal Year 2025

Price target decreased by 7.5% to US$11.33

Price target decreased by 7.8% to US$11.46

Walgreens Appoints Jason Stenta as SVP and Chief Commercial Officer

Walgreens Stock: Cheap At 3x FWD P/E, But Still Not Worth Buying

Saxena White P.A. Files New Securities Fraud Class Action Lawsuit Against Walgreens Boots Alliance, Inc. and Certain of its Executives

Price target decreased by 8.7% to US$12.43

Walgreens Boots Alliance, Inc. to Report Q4, 2024 Results on Oct 15, 2024

Is Walgreens Boots Alliance (NASDAQ:WBA) A Risky Investment?

Walgreens: Short Interest Surge Indicates It's Time To Cut Your Losses

Is Walgreens Ready To Rebound?

Walgreens Announces Executive Appointments

Upcoming dividend of US$0.25 per share

Walgreens Boots Alliance: Likely A Value Trap, But Could Be A Speculative Long-Term Play

Walgreens: A Painful Turnaround Lesson

Gross Law Firm Announces Lawsuit Against Walgreens Boots Alliance, Inc

Third quarter dividend of US$0.25 announced

Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on September 12, 2024

Walgreens: Here's What Comes Next

Walgreens: Yielding Over 8% Following The Earnings Drop

Boots Chief Quits Reportedly After Walgreens' Sale Plan Stalls

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Price target decreased by 9.0% to US$20.21

Consensus EPS estimates fall by 41%

Walgreens: Beware The Value Trap Ahead Of Earnings

Walgreens Boots Alliance, Inc. to Report Q3, 2024 Results on Jun 27, 2024

Walgreens: Another Dividend Cut Could Be Coming Soon (Rating Downgrade)

5 Reasons Walgreens Fell By 6.4% To Nearly 25-Year Lows

Walgreens Announces Launch of Walgreens Brand Naloxone HCI Nasal Spray

Walgreens Reportedly Contacts Potential Buyers for £7 Billion Boots Drugstore Chain

Upcoming dividend of US$0.25 per share

Walgreens: Hold Tight, Let It Turn Around First

Walgreens Boots Alliance (NASDAQ:WBA) Use Of Debt Could Be Considered Risky

Second quarter dividend of US$0.25 announced

Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on June 12, 2024

3 Reasons Walgreens Can See Upside (Rating Upgrade)

Investors Still Waiting For A Pull Back In Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Walgreens: New Management Team And Cost-Plus Model Are Exactly What The Doctor Prescribed

New major risk - Financial position

Consensus EPS estimates fall by 11%

Walgreens Earnings Preview: Revenue Estimates Holding Up; It's A Cost Structure Problem

Walgreens' Strategic Pivot

Consensus EPS estimates increase by 11%

Walgreens Q2, Dow Exit, And Bet Against Wall Street

Wisner Baum Files Multiple Class Actions Alleging Several Companies Sold Benzoyl Peroxide Acne Products Without Warning Consumers That They Contain Unsafe Levels of Benzene, a Potent Human Carcinogen

Walgreens Boots Alliance, Inc. to Report Q2, 2024 Results on Mar 28, 2024

Walgreens Boots Alliance, Inc. Names Lanesha Minnix as Executive Vice President and Global Chief Legal Officer

Consensus EPS estimates fall by 14%

Walgreens: New CEO Looking To Right The Ship

Walgreens Boots Alliance, Inc. Announces Executive Changes